235 related articles for article (PubMed ID: 11992742)
1. The promise of coxibs: how far have we progressed?
Schumacher HR
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S1-4. PubMed ID: 11992742
[No Abstract] [Full Text] [Related]
2. [Clinical use of COX-2 inhibitors].
Ristić GG; Stefanović DZ
Vojnosanit Pregl; 2001; 58(3):283-95. PubMed ID: 11548555
[No Abstract] [Full Text] [Related]
3. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
4. [Selective cyclooxygenase-2 inhibitor].
Hettich M; Thomae K
Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
[No Abstract] [Full Text] [Related]
5. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
Nasonova VA
Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
[No Abstract] [Full Text] [Related]
6. COX-1-sparing NSAIDs--is the enthusiasm justified?
Peterson WL; Cryer B
JAMA; 1999 Nov; 282(20):1961-3. PubMed ID: 10580464
[No Abstract] [Full Text] [Related]
7. COX-2 inhibitors: a review.
Houston AM; Teach SJ
Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
[No Abstract] [Full Text] [Related]
8. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
9. [Therapeutic advances with coxibs: few certainties and a lot of doubts].
Jouzeau JY; Daouphars M; Netter P
Therapie; 2004; 59(2):207-11. PubMed ID: 15359614
[No Abstract] [Full Text] [Related]
10. Controversies in COX-2 inhibitor therapy: closing remarks.
Abramson SB; Furst DE; Hochberg MC; Patrono C
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S77-80. PubMed ID: 11695257
[No Abstract] [Full Text] [Related]
11. COX-2 inhibitors. Magic bullets or merely mortal?
Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
[No Abstract] [Full Text] [Related]
12. [Arthrosis drugs critically evaluated. Emphasis on cartilage protection].
Wepner U
MMW Fortschr Med; 2002 Mar; 144(13):4-8. PubMed ID: 12001589
[No Abstract] [Full Text] [Related]
13. COX-1 and COX-2 inhibition: current status and future perspective.
Greyn J; Lauwers MH; Vanlersberghe C; Camu F
Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
[No Abstract] [Full Text] [Related]
14. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
15. [A new class of nonsteroidal anti-inflammatory agents: COXIBs].
Costantino S
Clin Ter; 2003; 154(1):5-6. PubMed ID: 12854276
[No Abstract] [Full Text] [Related]
16. An update on specific COX-2 inhibitors: the COXIBs.
Gupta S; Crofford LJ
Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
[No Abstract] [Full Text] [Related]
17. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
18. [Comparative safety of traditional non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors].
Bannwarth B
Presse Med; 2002 Dec; 31(39 Pt 2):4S7-9. PubMed ID: 12518070
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib: a COX-2 inhibitor.
Andrews SA; Wallace CK; Davis RL
Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
[No Abstract] [Full Text] [Related]
20. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.
Szczeklik A; Sanak M
Clin Exp Allergy; 2002 Mar; 32(3):339-42. PubMed ID: 11940059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
